Role of PML/RARα in the pathogenesis of APL

Drug Discovery Today: Disease Mechanisms

Volumn 3, Issue 4, 2006, Pages 499-505

  Laurenzana, Anna ^a   Pettersson, Filippa ^a   Miller Jr , Wilson H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ARSENIC TRIOXIDE; CYCLIC AMP DERIVATIVE; HISTONE DEACETYLASE INHIBITOR; HYBRID PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; CANCER RESISTANCE; CHROMOSOME TRANSLOCATION; DISEASE MODEL; DRUG MECHANISM; GENE MUTATION; GENE REARRANGEMENT; HUMAN; LEUKEMIA REMISSION; LEUKEMOGENESIS; MOLECULAR CLONING; NONHUMAN; PATHOGENESIS; PROMYELOCYTIC LEUKEMIA; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

EID: 33847009555     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2006.11.008     Document Type: Review

References (41)

1. Warrell R.P., et al. Acute promyelocytic leukemia. New Engl. J. Med. 329 (1993) 177-189
2. Schlenk R.F., et al. High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia 19 (2005) 978-983
3. Shigeno K., et al. Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies. Int. J. Hematol. 83 (2005) 224-229
4. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10 (1996) 940-954
5. Freedman L.P. Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97 (1999) 5-8
6. Melnick A., and Licht J.D. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93 (1999) 3167-3215
7. Tsai S., and Collins S.J. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage. Proc. Natl. Acad. Sci. U S A 90 (1993) 7153-7157
8. Kastner P., et al. Function of RARα during the maturation of neutrophils. Oncogene 20 (2001) 7178-7185
9. Rowley J.D., et al. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1 (1977) 549-550
10. Huang M.E., et al. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72 (1988) 567-572
11. Miller Jr. W.H., et al. Novel retinoic acid receptor-alpha transcripts in acute promyelocytic leukemia responsive to all-trans-retinoic acid. J. Natl. Cancer Inst. 82 (1990) 1932-1933
12. de The H., et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347 (1990) 558-561
13. Kasizuka A., et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor PML. Cell 66 (1991) 663-674
14. de The H., et al. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66 (1991) 675-684
15. Grignani F., et al. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes cell survival of myeloid precursor cells. Cell 74 (1993) 423-431
16. Grisolano J.L., et al. Altered myeloid development and acute myeloid leukemia in transgenic mice expressing PML-RARα under the control of cathepsin G regulatory sequences. Blood 89 (1997) 376-387
17. Kelly L.M., et al. PML/RAR alpha and FLT3-ITD induce APL-like disease in a mouse model. Proc. Natl. Acad. Sci. U S A 99 (2002) 8283-8288
18. Miller Jr. W.H., et al. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc. Natl. Acad. Sci. U S A 89 (1992) 2694-2698
19. Perez A., et al. PML-RAR homodimers: distinct DNA binding properties and heteromeric interaction with RXR. EMBO J. 12 (1993) 3171-3182
20. Grignani F., et al. Fusion proteins of the retinoic receptor-α recruit histone deacetylases in acute promyelocyte leukaemia. Nature (Lond.) 391 (1998) 815-818
21. Licht D.J. Reconstructing a disease: what essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia?. Cancer Cell 9 (2006) 73-74
22. Zhu J., et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins. Proc. Natl. Acad. Sci. U S A 96 (1999) 14807-14812
23. Nervi C., et al. Caspases mediate retinoic acid-induced degradation of the acute promyelocyte leukemia PML/RARalpha fusion protein. Blood 92 (1998) 2244-2251
24. Lane A.A., and Ley T.J. Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice. Cell 115 (2003) 305-318
25. Kogan S.C., et al. Leukemia initiated by PML/RARa: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood 95 (2000) 1541-1550
26. Zhong S., et al. Role of SUMO-1-modified PML in nuclear body formation. Blood 95 (2000) 2748-2752
27. Chen S.J., et al. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. J. Clin. Invest. 91 (1993) 2260-2267
28. Melnick A., et al. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell. Biol. 22 (2002) 1804-1818
29. Redner R.L., et al. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87 (1996) 882-886
30. Wells R.A., et al. Fusion of retinoic acid receptor a to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukemia. Nat. Gen. 17 (1997) 109-113
31. Arnould C., et al. The signal transducer and activator of transcription factor STAT5b gene is a new partner of retinoic acid receptor [alpha] in acute promyelocytic leukemia. Human Mol. Gen. 8 (1999) 1741-1749
32. Zhou J., et al. Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML-RARA-induced immortalization. Proc. Natl. Acad. Sci. U S A 103 (2006) 9238-9243
33. Sternsdorf T., et al. Forced retinoic acid receptor α homodimers prime mice for APL-like leukemia. Cancer Cell 9 (2006) 81-94
34. Zhu J., et al. A sumoylation site in PML/RARA is essential for leukemic transformation. Cancer Cell 7 (2005) 143-153
35. Shao W., et al. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation. Blood 89 (1997) 4282-4289
36. Cote S., et al. Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells. Blood 100 (2002) 2586-2596
37. Zhou D.C., et al. Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. Blood 99 (2002) 1356-1363
38. Di Croce L., et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295 (2002) 1079-1082
39. Witcher M., et al. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells. Blood 104 (2004) 3335-4334
40. Zhao Q., et al. Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation. Leukemia 18 (2004) 285-292
41. Kamashev D., et al. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation. J. Exp. Med. 199 (2004) 1163-1174